Capromab Pendetide immunoscintigraphy: connecting the dots for prostate cancer imaging

Cancer Biother Radiopharm. 2000 Apr;15(2):127-30. doi: 10.1089/cbr.2000.15.127.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Adenocarcinoma / diagnostic imaging*
  • Adenocarcinoma / pathology
  • Adenocarcinoma / radiotherapy
  • Adenocarcinoma / surgery
  • Algorithms
  • Antibodies, Monoclonal*
  • Combined Modality Therapy
  • Evaluation Studies as Topic
  • False Negative Reactions
  • Humans
  • Logistic Models
  • Lymphatic Metastasis
  • Male
  • Multicenter Studies as Topic
  • Predictive Value of Tests
  • Preoperative Care
  • Prostatectomy
  • Prostatic Neoplasms / diagnostic imaging*
  • Prostatic Neoplasms / pathology
  • Prostatic Neoplasms / radiotherapy
  • Prostatic Neoplasms / surgery
  • Radioimmunodetection*
  • Risk
  • Salvage Therapy
  • Tomography, Emission-Computed, Single-Photon*

Substances

  • Antibodies, Monoclonal
  • Capromab Pendetide